Prizes
WIPO General Assembly: Expectations loom over decisions on treaties for actors, reading disabled persons and genetic resources
Submitted by thiru on 28. July 2011 - 10:43The WIPO General Assembly meets from Monday, 26 September 2011 to Wednesday, 5 October 2011 and will take place at the International Conference Center Geneva (CICG), 17 rue de Varembé, 1211, Geneva.
The tentative schedule for 49th session of the WIPO General Assembly can be found here: http://www.wipo.int/edocs/mdocs/govbody/en/a_49/a_49_1_prov_2.pdf.
April 2011: WHO to tackle pandemic influenza, de-linkage, prizes, R&D financing and non-communicable diseases
Submitted by thiru on 18. March 2011 - 4:16April 2011 ushers in a busy period for the World Health Organization.
SAVE THE DATE: 19 May 2010-Moving beyond the EWG: Charting a new path for WHO to promote innovation AND access to medicines
Submitted by thiru on 18. May 2010 - 11:05Moving beyond the EWG: Charting a new path for WHO to promote innovation AND access to medicines
Non-governmental organization perspectives on de-linkage, prizes and the R+D Treaty
Date: Wednesday, 19 May 2010
Location: Salle XXV, Palais des Nations
Time: 13:00 to 14:30
I+A: Innovation+Access
Bolivian statement to EB 126 (Jan 2010) on public health, innovation and intellectual property
Submitted by thiru on 20. January 2010 - 0:07This is the statement that the Government of Bolivia delivered on January 19, 2010 at the 126th session of the WHO Executive Board public health, innovation and intellectual property including their views on the EWG process and the Executive Summary of the WHO Expert Working Group on R&D Financing.
The heart of Bolivia's intervention is encapsulated in the penultimate paragraph of their intervention.
Official executive summary of the report of the WHO Expert Working Group on Research and Development Financing
Submitted by thiru on 23. December 2009 - 13:5423 December 2009
The Official Executive Summary and Recommendations of the Report of the Expert Working Group on Research and Development Financing to the Executive Board has been published on the website of the WHO Executive Board as document EB126/6 Add.1. It has a provisional agenda item number of 4.3. The official WHO link to this Executive Summary is: http://apps.who.int/gb/ebwha/pdf_files/EB126/B126_6Add1-en.pdf
Second round of public submissions to WHO Expert Working Group on R&D Financing
Submitted by thiru on 17. November 2009 - 3:42November 17, 2009
Speech of Mike Foster, UK Minister for International Development at launch of Industry Government Forum on Access to Medicines
Submitted by thiru on 21. October 2009 - 4:32On October 12, 2009, the "Industry Government Forum on Access to Medicines" (IGFAM) was launched. The UK Minister for International Development, MP Mike Foster made a a speech to launch this initiative which is reproduced below.
Presentations were also made by Pfizer (Ponni Subbiah), GSK (Abbas Hussain), Rajiv Venkayya (Gates Foundation), Prashant Yadav (Massachusetts Institute of Technology) and Suerie Moon (Research Fellow and Doctoral Candidate, Kennedy School of Government, Harvard University).
John Edwards calls for prizes to replace monopolies as innovation incentive for new drugs
Written by James Love
Friday, 15 June 2007
Friday, 15 June 2007
John Edwards, a leading candidate for the democratic nomination for president of the United States, has issued a statement endorsing prizes as an "alternative to patent monopolies" for new drugs and other inventions. This was from the Edwards campaign press release:
Edwards Details Cost-Savings Measures In Universal Health Care Plan, Jun 14, 2007
The Big Idea: Prizes to Stimulate R&D for New Medicines
Chicago-Kent Law Review
Volume 82, Number 3
2007
Previously KEI Research Paper 2007:1, Revised 26 March 2007. Originally the Ruby Hutchison
Memorial Address, Presented November 14, 2006
James Love, Knowledge Ecology International
Tim Hubbard, Wellcome Trust Sanger Institute
The paper is available in PDF format here: http://lawreview.kentlaw.edu/articles/82-3/Love
